Dr. Levandovsky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1211 S. Parker Rd
Suite 200
Denver, CO 80231Phone+1 720-893-9515Fax+1 720-893-7050
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2005 - 2008
- University of California Davis HealthResidency, Internal Medicine, 2001 - 2004
- University of California, Irvine, School of MedicineClass of 2001
Certifications & Licensure
- FL State Medical License 2023 - Present
- CA State Medical License 2021 - 2025
- CO State Medical License 2015 - 2025
- AK State Medical License 2009 - 2018
- NY State Medical License 2005 - 2008
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score Start of enrollment: 2012 May 01
- LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE) Start of enrollment: 2014 Aug 25
Publications & Presentations
PubMed
- 29 citationsThrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): a 24-year clinical experience with 178 patientsMark Levandovsky, Danielle J Harvey, Primo N. Lara, Theodore Wun
Journal of Hematology & Oncology. 2008-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: